These suggest that ICT triggers the antitumor immunity in lung cancer by regulating inflammatory signaling pathways and increases immune chemokines expression instead of downregulating PD-L1 pathway as in hepatic cell carcinoma. Here, CD274 is linked to lung carcinoma.